Still no solution in sight between the European Union and the AstraZeneca laboratory concerning the delays in the delivery of vaccines against Covid-19 (see EUROPE B12643A2). The two parties therefore agreed, after two virtual meetings at the beginning of the week, to resume their discussions on the evening of Wednesday 27 January.
“As in any complex process, giving yourself a little time helps the process. We have asked AstraZenecaa number of questions and hope for answers at our...